Which of the 20,000+ potential protein drug targets
are most promising for allosteric control?
Rapid triangulation of the target space by connecting sequence, structure and mechanism data using AI.
Two targets in Lead Optimization plus more in the pipeline (as of 9/2021).
HotSpot Therapeutics is a Boston-based biotech company targeting nature’s regulatory mechanisms to create new allosteric medicines that exhibit high precision and potency.
“idalab have worked seamlessly with our research leaders to implement a target discovery engine that captures our unique insights but can be scaled across biological classes”